FLT3 anticorps (AA 930-991)
Aperçu rapide pour FLT3 anticorps (AA 930-991) (ABIN1724846)
Antigène
Voir toutes FLT3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 930-991
-
Fonction
- FLT3 Antibody
-
Purification
- Purified antibody
-
Immunogène
- Purified recombinant fragment of human FLT3 (AA: 930-991) expressed in E. Coli.
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- ELISA: 1/10000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "Inhibitors of DNA binding proteins restrict T cell potential by repressing Notch1 expression in Flt3-negative common lymphoid progenitors." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 189, Issue 8, pp. 3822-30, (2012) (PubMed).
: "Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia." dans: Cancer, Vol. 118, Issue 24, pp. 6110-7, (2012) (PubMed).
-
-
- FLT3 (Fms-Related tyrosine Kinase 3 (FLT3))
-
Autre désignation
- FLT3
-
Sujet
-
This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.
-
Poids moléculaire
- 130 kDa
-
ID gène
- 2322
-
UniProt
- P36888
-
Pathways
- Signalisation RTK
Antigène
-